Each participant also completed a post-trial questionnaire Outco

Each participant also completed a post-trial questionnaire. Outcome measures and assessment Fluid administration times (in seconds) were determined from video review by two independent outcome assessors blinded to the purpose #selleck kinase inhibitor randurls[1|1|,|CHEM1|]# of the trial. For each video, the assessors were asked to determine four separate fluid administration times based upon a clear, a priori defined protocol to ensure consistency. A common software

program (Apple Quicktime™) was used to review the trial videos and the time bar function was used to identify times in the video frame sequence. Time outcomes Inhibitors,research,lifescience,medical extracted included time to administer the full 900 mL (60 mL/kg) of NS (primary outcome measure) and times to administer each of the three 300 mL (20 mL/kg) aliquots of NS, (secondary outcome measure). For the purposes of final data analysis, the times of the two independent assessors

were averaged for each outcome of interest. Descriptive Inhibitors,research,lifescience,medical data regarding the characteristics of participants were ascertained from the post-trial questionnaire. The questionnaire also asked participants to recall and rate their level of fatigue following each 20 mL/kg bolus on a 7-point Likert scale. Catheter dislodgement events (defined as physical displacement/removal from the conduit tubing) were noted by Inhibitors,research,lifescience,medical the research assistant selleck chem Imatinib Mesylate during testing and on the data collection form. The volume of normal saline actually received by the model Inhibitors,research,lifescience,medical was determined by the research assistant

by measuring the amount of fluid collected in the graduated cylinder. Statistical analyses and sample size considerations The analysis results of subject baseline characteristics and outcome variables (both primary and secondary) were summarized using descriptive Inhibitors,research,lifescience,medical summary measures: expressed as mean (standard deviation) or median (minimum-maximum) for continuous variables and number (percent) for categorical variables. Final statistical analyses were performed using SAS (SAS Institute Inc., Cary, NC, USA), although SPSS (IBM Corporation, Armonk, NY, USA) was used for some preliminary analyses and figure generation. The primary outcome was analysed using Drug_discovery a One-way ANOVA analysis, with post hoc comparison of syringe group total intervention time means using Tukey’s HSD. Secondary outcome analyses consisted of Generalized Linear Model (GLM) with repeated measures in order to compare bolus administration times and fatigue scores for each of the three sequential aliquots. We planned to use Chi-square testing to compare the proportion of catheter dislodgement events by syringe size group. One-way ANOVA was used to compare the mean volume of normal saline received by the model according to syringe size group. A two-way random effects model was used to compare the agreement of our blinded outcome assessors (both observer and subject were treated as random effects) [12].

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>